Aminolab Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Aminolab General Information

Description

Developer of blood resource recycling technology designed to identify issues related to the environmental burden of waste blood treatment. The company's unique enzyme-based biotechnology turns slaughter blood into a highly nutritious life resource, providing clients with food raw materials, cosmetics, feed additives, and plant nutrients made from high-quality amino acids.

Contact Information

Website
www.aminolab.co.kr
Formerly Known As
Nanum
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 27, Gangnam-daero, Seocho-gu
  • Number 702
  • Seoul
  • South Korea
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Vertical(s)
CleanTech, Life Sciences
Corporate Office
  • 27, Gangnam-daero, Seocho-gu
  • Number 702
  • Seoul
  • South Korea

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aminolab Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Out of Business 08-Sep-2022 Completed Out of Business
6. Later Stage VC 01-Dec-2019 Completed Generating Revenue
5. Later Stage VC 01-Jan-2019 Completed Generating Revenue
4. Early Stage VC 01-Dec-2017 Completed Generating Revenue
3. Early Stage VC 01-Dec-2016 Completed Generating Revenue
2. Early Stage VC 01-Sep-2016 $314K $501K Completed Generating Revenue
1. Early Stage VC 01-Nov-2013 $187K $187K Completed Generating Revenue
To view Aminolab’s complete valuation and funding history, request access »

Aminolab Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 2

    Pending

  • Expiring in next 12 mo

Aminolab Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260354414-A1 Whole blood feed composition hydrolyzed by serine protease for increasing productivity and immunity of weaned piglet Pending 08-May-2025
US-20250000902-A1 Method for production of bioactive substance using blood and application thereof Pending 26-Oct-2021
WO-2023074991-A1 Method for production of bioactive substance using blood and application thereof Inactive 26-Oct-2021 A61K35/16

Ready to get started?

Request a free trial

Aminolab FAQs

  • When was Aminolab founded?

    Aminolab was founded in 2013.

  • Where is Aminolab headquartered?

    Aminolab is headquartered in Seoul, South Korea.

  • What industry is Aminolab in?

    Aminolab’s primary industry is Biotechnology.

  • Is Aminolab a private or public company?

    Aminolab is a Private company.

  • What is Aminolab’s current revenue?

    The current revenue for Aminolab is .

  • How much funding has Aminolab raised over time?

    Aminolab has raised $759K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process